LSMS
The Legisla Ɵ ve Edi Ɵ on
June/July 2024
Freeman’s legisla Ɵ on requires any health insurer o ff ering coverage in Louisiana to cover any medically necessary care or treatment for menopause and perimenopause. Furthermore, the insurer shall not require a prior authoriza Ɵ on or otherwise subject a pa Ɵ ent to a step -therapy or fail- fi rst policy or protocol for the administra Ɵ on or prescrip Ɵ on of any medica Ɵ on administered or prescribed for hormone replacement therapy used to treat symptoms of menopause and perimenopause.
interim to educate legislators in hopes of bringing the bill next year. ACT 122 (SB 55) was introduced by Sen. Gary Carter (SD 7 – D). As passed, ACT 122 requires the LA Department of Health to develop informa Ɵ on on “post-birth warning signs, including symptoms and available resources” which shall be included on the department’s website. In turn, hospitals and birthing centers that provide labor and delivery services must provide the mother and her family with this informa Ɵ on. ACT 299 (SB 143) was introduced by Sen. Regina Barrow (SD 15 – D). Sen. Barrow’s legisla Ɵ on requires any healthcare provider who provides prenatal and postpartum care to a woman to screen for hypertension and preeclampsia using an ACOG validated tool if in your medical judgment you believe the screening to be in the best interest of the pa Ɵ ent. ACT 301 (SB 148) was introduced by Sen. Beth Mizell (SD 12 – R). Sen. Mizell successfully gave a prescriber the ability to request a fail- fi rst override when being required to use a drug o ff -label for postpartum depression. * ACT 246 (SB 276) was introduced by Sen. Thomas Pressly (SD 38 – R). This legisla Ɵ on was actually introduced to criminalize the use of abor Ɵ on-inducing drugs on a mother without her consent. An amendment to the bill by the House Health and Welfare Commi Ʃ ee has added Mifepristone and Misoprostol to the Louisiana Uniform Controlled Dangerous Substances List as Schedule IV drugs.
session – the largest number in any of our categories. As expected, none of the legisla Ɵ on that would have impacted Louisiana’s abor Ɵ on statutes got out of a commi Ʃ ee this year. HB 63 was introduced by Rep. Candace Newell (HD 99 – D). Rep. Newell took in all the informa Ɵ on, comments and concerns o ff ered to her and others during debates held in the 2023 Session. (Rep. Newell brought HB 598 and former Rep. Mary DuBuisson brought HB 461 in
Watch our video to learn how to use the legisla Ɵ ve website to look up informa Ɵ on on any bill fi led.
h Ʃ ps://legis.la.gov/legis/BillSearch.aspx?sid=last
HB 833 was o ff ered by Rep. Paula Davis (HD 69 – R). Rep. Davis a Ʃ empted to protect in vitro fer Ɵ liza Ɵ on treatment in Louisiana following challenges in other states. The legisla Ɵ on would have updated de fi ni Ɵ ons which currently classify “embryos” as “human beings.” In Louisiana, criminal statutes refer to “human beings,” meaning physicians and healthcare a Ʃ orneys could bear criminal liability. A Ō er a needed amendment didn’t get on the bill in Senate Commi Ʃ ee, Rep. Davis opted to let the bill die on the calendar. She has said she will work in the
2023.) While the bill did not get reported from commi Ʃ ee, many legislators have acknowledged that physicians are telling them the current statute is not clear and that they have concerns about what a pa Ɵ ent can experience – in par Ɵ cular during an emergent situa Ɵ on. * HB 392 was o ff ered by Rep. Aimee Freeman (HD 98 – D). Rep. Freeman worked with Sen. Thomas Pressly (SD 38 – R) to o ff er substan Ɵ ve amendments to HB 392 on the Senate fl oor. As passed, Rep.
- Con Ɵ nued on Page 6 -
Page 5
Made with FlippingBook Digital Publishing Software